- ConvaTec, HemCon sign promotion deal for wound care products. // Medical Device Daily;4/16/2009, Vol. 13 Issue 72, p5
The article reports on a co-promotion agreement signed by ConvaTec with HemCon Medical Technologies to market ConvaTec advanced wound and critical care products to the U.S. Armed Forces. The agreement has granted HemCon sales and marketing rights to ConvaTec's Aquacel and Aquacel Ag dressings...
- Transparency must prevail. Butcher, Martyn // British Journal of Nursing;2014 TV Supplement, Vol. 23, pS3
The author reflects on wound care in Great Britain. He suggests that the issue of wound care has been poorly represented in medical research and that research has failed to find a gold standard for wound care. He argues that if medical researchers want clinicians to incorporate their findings on...
- Are new therapies for faecal incontinence cost effective? // PharmacoEconomics & Outcomes News;May2014, Vol. 703 Issue 1, p3
The article discusses research by M. A. Bernstein and colleagues, published in "Clinical Therapeutics" on the treatments approved by the U.S. Food and Drug Administration for faecal incontinence, non-animal stabilized hyaluronic acid and dextranomer copolymer and sacral nerve stimulation.
- Weak in the knees? Lewis, Wendy // Joe Weider's Muscle & Fitness;Sep98, Vol. 59 Issue 9, p200
Discusses the use of hylan, an injectable material from hyaluronan, for treating weak knees. Route of applying hylan; Brand names for hylan injectables; Effectiveness of hylan.
- A new association between hyaluronic acid and collagenase in wound repair: an open study. ONESTI, M. G.; FIORAMONTI, P.; CARELLA, S.; FINO, P.; SORVILLO, V.; SCUDERI, N. // European Review for Medical & Pharmacological Sciences;Jan2013, Vol. 17 Issue 2, p210
BACKGROUND: Most ulcers occur with slough and need debridement treatment. Surgical treatment is usually performed but many patients need an additional chemical therapy to promote healing process. This type of wound bed preparation is slower than surgical one, but it is essential in those...
- The Patient Outcome Group. Price, Pratricia // EWMA Journal;May2012, Vol. 12 Issue 2, p60
The article presents information on the Patient Outcome Group (POG) of the European Wound Management Association (EWMA) that has received a deal interest from the European as well as international stakeholders in the research activities of the group.
- Missing Possible Connections between Basic Research and Clinical Reality: Early Detection of Cancer as a Case In Point. Retsky, Michael // Journal of Bioequivalence & Bioavailability;2012, Vol. 4 Issue 7, p1
The author reflects on the issue concerning the association between basic research and clinical data in terms of early detection of cancer. The author cites a basic researcher who talked about his work using the TRAMP animal model of prostate cancer at a seminar. He notes that the researcher was...
- Results bolster diagnostic value of PCa biomarker. Guttman, Cheryl // Urology Times;11/1/2008, Vol. 36 Issue 14, p14
The article reports on the findings of the studies regarding the prevalence of TMPRSS2-ERG gene fusion prostate cancer in men undergoing prostate biopsy in the U.S., and the performance of DNA methylation, and TMPRSS2-ERG gene fusion as prostate cancer biomarkers. One of the studies found that...
- Evidence in wound care: the recent NICE guidance on Debrisoft monofilament debridement pad for use in acute or chronic wounds. WHITE, RICHARD; GROCOTT, PATRICIA; YOUNG, TRUDIE; ALI, OMAR // Wounds UK;Jun2014, Vol. 10 Issue 2, p20
The article discusses the views of the authors about the medical technology guidance on wound debridement from Great Britain National Institute for Health and Care Excellence (NICE) that was released in March 2014. One of the authors stresses that it does not confined to evidence in wound care...